Download PDF
Diabetes aktuell 2018; 16(05): 180-181
DOI: 10.1055/a-0655-5752
Gesellschaft | VDBD
© Georg Thieme Verlag Stuttgart · New York

Der Weg zur richtigen Diagnose

Labordiagnostik des Diabetes mellitus
Sebastian Hörber
1   Medizinische Klinik IV – Zentrallabor, Universitätsklinikum Tübingen
,
Andreas Peter
1   Medizinische Klinik IV – Zentrallabor, Universitätsklinikum Tübingen
› Author Affiliations
Further Information

Publication History

Publication Date:
05 September 2018 (online)

Also available at
    Permissions and Reprints

Labormedizinische Bestimmungen spielen eine entscheidende Rolle bei der Diagnose, Therapiekontrolle und Prognoseeinschätzung des Diabetes mellitus. Bestimmt werden können Nüchternplasmaglukose, Gelegenheitsplasmaglukose, 2h-Plasmaglukose und der HbA1c-Wert. Dabei ist es wichtig die Vor- und Nachteile der verschiedenen Methoden zu kennen.

 

  • Literatur

  • 1 Nauck M, Petermann A, MÜller-Wieland D. et al. Definition, Klassifikation und Diagnostik des Diabetes mellitus.. Diabetologie 2017; 12 (Suppl. 02) S94-S100
    Article in Thieme ConnectGoogle Scholar
  • 2 American Diabetes Association. 2. classification and diagnosis of diabetes: standards of medical care in diabetes-2018.. Diabetes Care 2018; (Suppl. 01) S13-S27
    PubMedGoogle Scholar
  • 3 Peter A, Fritsche A, Stefan N. et al. Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in a population at risk.. Exp Clin Endocrinol Diabetes 2011; 4: 234-237
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Selvin E, Steffes MW, Zhu H. et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.. N Engl J Med 2010; 362: 800-811
    CrossrefPubMedGoogle Scholar
  • 5 Bundesärztekammer. Richtlinie zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen.. Dtsch Arztebl 2008; 111: A341-355
    Google Scholar
  • 6 Larsson-Cohn U.. Differences between capillary and venous blood glucose during oral glucose tolerance tests.. Scand J Clin Lab Invest 1976; 8: 805-808
    Google Scholar
  • 7 D’Orazio P, Burnett RW, Fogh-Andersen N. et al. Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT).. Clin Chem Lab Med 2006; 12: 1486-1490
    Google Scholar
  • 8 Bundesärztekammer (BäK), K.B.K., Arbeitsgemeinschaft der Wissenschaftlichen and M.F. (AWMF). Nationale VersorgungsLeitlinie Therapie des Typ-2-Diabetes – Langfassung.. zuletzt geändert: April 2014: Available from:. http://www.versorgungsleitlinien.de/themen/diabetes2/dm2_therapie ;[cited:02.05.2018]
    Google Scholar
  • 9 The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.. Diabetes Care 2009; 7: 1327-1334
    Google Scholar
  • 10 Hanas R, John G. and the International HbA1c Consensus Committee. 2010 consensus statement on the worldwide standardization of the hemoglobin A1c measurement.. Clin Chem 2010; 8: 1362-1364
    Google Scholar
  • 11 Kaiser P, Spannagl M, van Campenhout C. et al. HbA1c: EQA in Germany, Belgium and the Netherlands using fresh whole blood samples with target values assigned with the IFCC reference system.. Clin Chem Lab Med 2016; 11: 1769-1775
    Google Scholar
  • 12 Dagogo-Jack S.. Pitfalls in the use of HbA1(c) as a diagnostic test: the ethnic conundrum.. Nat Rev Endocrinol 2010; 10: 589-593
    Google Scholar
  • 13 Cohen RM, Franco RS, Khera PK. et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.. Blood 2008; 10: 4284-4291
    Google Scholar
  • 14 Pani LN, Korenda L, Meigs JB. et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001–2004.. Diabetes Care 2008; 10: 1991-1996
    Google Scholar